Literature DB >> 22290844

Sulpiride-induced tardive dyskinesia in a person with Gilles de la Tourette syndrome.

V Eapen1, C L Katona, T R Barnes, M M Robertson.   

Abstract

A 48 year old man who had never been treated with any other major tranquilliser developed tardive dyskinesia (TD) while taking sulpiride for Gilles de la Tourette syndrome (GTS). To our knowledge, this is the first report of TD complicating the use of sulpiride in the treatment of GTS.

Entities:  

Year:  1993        PMID： 22290844     DOI： 10.1177/026988119300700309

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN： 0269-8811            Impact factor:   4.153


  4 in total

Review 1.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

2.  Treatment strategies for tics in Tourette syndrome.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

3.  Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.

Authors:  Alessandro S De Nadai; Eric A Storch; Joseph F McGuire; Adam B Lewin; Tanya K Murphy
Journal:  J Cent Nerv Syst Dis       Date:  2011-06-01

4.  Risks of Sulpiride-Induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients in Taiwan: A Nationwide Population-Based Study.

Authors:  Cheng-Yu Wei; I-Shiang Tzeng; Mei-Chen Lin; Yung-Hsiang Yeh; Chung Y Hsu; Woon-Man Kung
Journal:  Front Pharmacol       Date:  2020-04-24       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.